Treatment of Major Depressive Disorder with Ketamine - retrospective data analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022836

Enrollment

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32

Interventions

Group 1: Retrospective data analysis of individual treatment trials with Ketamine in patients with Major Depressive Disorder

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All Patients with Major Depressive Disorder who were treated between 2014 and July 2020 in the Dept. of Psychiatry Freiburg (ward 5) at minimum once with ketamine or esketamine for an individual treatment trial. The study population comprises about 50 subjects with about 600 single treatments.

Exclusion criteria

Exclusion criteria: All patients who do not fulfill the inclusion criteria.

Design outcomes

Primary

Measure	Time frame
The aim of the trial ist getting more insight concerning dosis, kind of application, protocol of treatment, efficacy and side effects in treatment of Major Depressive Disorder with Ketamine.	—

Countries

Germany

Contacts

Public ContactClaus Normann

Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg

claus.normann@uniklinik-freiburg.de+49 761 270-65010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026